Abstract
Hürthle cell neoplasms are a distinct category of thyroid neoplasms that originate from metaplastic thyroid follicular epithelial cells. Hürthle cells are identified by the presence of abundant, granular cytoplasm that is brightly eosinophilic on hematoxylin and eosin staining and contain numerous mitochondria ultrastructurally. On alcohol-fixed Papanicolaou-stained slides, the cells have abundant green, blue, or orange cytoplasm, while on air-dried Romanowsky-stained slides, the cells have abundant blue or gray-pink cytoplasm. Both of these slide preparations are routinely examined in our practice on the vast majority of our thyroid specimens. A number of controversies have surrounded Hürthle cell neoplasms since their original description, including whether it is possible to separate benign from malignant Hürthle cell lesions cytologically, or even histologically. A number of entities, both neoplastic and nonneoplastic, that are in the differential diagnosis of Hürthle cell neoplasms are discussed. As do most laboratories in the United States, we categorize our thyroid aspirates according to the Bethesda System for Reporting Thyroid Cytopathology and do not attempt to separate Hürthle cell adenomas from Hürthle cell carcinomas on cytology specimens.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Renshaw AA. Hürthle cell carcinoma is a better gold standard than Hürthle cell neoplasm for fine-needle aspiration of the thyroid: defining more consistent and specific cytologic criteria. Cancer. 2002;96(5):261–6.
Faquin W, Michael C, Renshaw A, Vielh P. In: Ali S, Cibas E, editors. The Bethesda system for reporting thyroid cytopathology: definitions, criteria and explanatory notes. 2nd ed. Gewerbestrasse: Springer; 2018. p. 81–100.
Baloch ZW, LiVolsi VA, Asa SL, Rosai J, Merino MJ, Randolph G, et al. Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: a synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference. Diagn Cytopathol. 2008;36(6):425–37. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18478609
Kini SR. Thyroid cytopathology: an Atlas and text. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2015. p. 119–52.
Bernadt CT, Collins BT. Fine-needle aspiration biopsy of Hürthle cell neoplasms of the thyroid. Pathol Case Rev. 2015;20(3):121–4. Available from: http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00132583-201505000-00005
Mete O, Asa SL. Oncocytes, oxyphils, Hürthle, and Askanazy cells: morphological and molecular features of oncocytic thyroid nodules. Endocr Pathol. 2010;21(1):16–24.
Auger M. Hürthle cells in fine-needle aspirates of the thyroid: a review of their diagnostic criteria and significance. Cancer Cytopathol. 2014;122(4):241–9.
Hurthle K. A study of the secretory process of the thyroid gland. Arch F D Ges Physiol. 1894;56:10–44.
Askanazy M. Pathologisch-anatomische beitrage zure kenntnis des morbus basedowii, insbesondere uber die dabei auftretende muskelergrankung. Dtsch Arch Klin Med. 1898;61:118.
Asa SL. My approach to oncocytic tumours of the thyroid. J Clin Pathol. 2004;57(3):225–32.
Tulecke MA, Wang HH. ThinPrep® for cytologic evaluation of follicular thyroid lesions: correlation with histologic findings. Diagn Cytopathol. 2004;30(1):7–13.
Chong Y, Ji S-J, Kang CS, Lee EJ. Can liquid-based preparation substitute for conventional smear in thyroid fine-needle aspiration? A systematic review based on meta-analysis. Endocr Connect. 2017;6(8):817–29. https://doi.org/10.1530/EC-17-0165. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29018157%0A, http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC5682413%0A
Montone KT, Baloch ZW, LiVolsi VA. The thyroid Hurthle (oncocytic) cell and its associated pathologic conditions: a surgical pathology and cytopathology review. Arch Pathol Lab Med. 2008;132(8):1241–50.
Máximo V, Lima J, Prazeres H, Soares P, Sobrinho-Simões M. The biology and the genetics of Hürthle cell tumors of the thyroid. Endocr Relat Cancer. 2012;19(4):131–47.
LiVolsi V, Baloch ZW, Sobrinho Simoes M, Tallini G. In: Lloyd RV, Osamura RY, Kloppel G, Rosai J, editors. WHO classification of tumours of endocrine organs. 4th ed. Lyon: IARC Press; 2017. p. 96–9
Nikiforova MN, Biddinger PW, Caudill CM, Kroll TG, Nikiforov YE. PAX8-PPARgamma rearrangement in thyroid tumors: RT-PCR and immunohistochemical analyses. Am J Surg Pathol. 2002;26(8):1016–23. Available from http://www.ncbi.nlm.nih.gov/pubmed/12170088
Thompson NW, Dunn EL, Batsakis JG, Nishiyama RH. Hürthle cell lesions of the thyroid gland. Surg Gynecol Obstet. 1974;139(4):555–60. Available from: http://www.ncbi.nlm.nih.gov/pubmed/4479589
Gundry SR, Burney RE, Thompson NW, Lloyd R. Total thyroidectomy for Hürthle cell neoplasm of the thyroid. Arch Surg. 1983;118(5):529–32. Available from: http://www.ncbi.nlm.nih.gov/pubmed/6838358
Goldstein NS, Czako P, Neill JS. Metastatic minimally invasive (encapsulated) follicular and Hurthle cell thyroid carcinoma: a study of 34 patients. Mod Pathol. 2000;13(2):123–30.
Stojadinovic A, Ghossein RA, Hoos A, Urist MJ, Spiro RH, Shah JP, et al. Hürthle cell carcinoma: a critical histopathologic appraisal. J Clin Oncol. 2001;19(10):2616–25. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11352953
Carcangiu ML, Bianchi S, Savino D, Voynick IM, Rosai J. Follicular Hurthle cell tumors of the thyroid gland. Cancer. 1991;68(9):1944–53.
Shaha AR, Loree TR, Shah JP. Prognostic factors and risk group analysis in follicular carcinoma of the thyroid. Surgery. 1995;118(6):1131–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/7491533
Evans HL, Vassilopoulou-Sellin R. Follicular and Hurthle cell carcinomas of the thyroid: a comparative study. Am J Surg Pathol. 1998;22(12):1512–20. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9850177
Barnabei A, Ferretti E, Baldelli R, Procaccini A, Spriano G, Appetecchia M. Hurthle cell tumours of the thyroid. Personal experience and review of the literature. Acta Otorhinolaryngol Ital. 2009;29(6):305–11. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20463834%5C, http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC2868205
Kini SR, Miller JM, Hamburger JI. Cytopathology of Hürthle cell lesions of the thyroid gland by fine needle aspiration. Acta Cytol. 1981;25(6):647–52. Available from: http://www.ncbi.nlm.nih.gov/pubmed/6171979
Nguyen GK, Husain M, Akin MRM. Cytodiagnosis of benign and malignant Hurthle cell lesions of the thyroid by fine-needle aspiration biopsy. Diagn Cytopathol. 1999;20(5):261–5.
Elliott DD, Pitman MB, Bloom L, Faquin WC. Fine-needle aspiration biopsy of Hurthle cell lesions of the thyroid gland: a cytomorphologic study of 139 cases with statistical analysis. Cancer. 2006;108(2):102–9.
Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016;26(1):1–133.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Wasman, J. (2019). Hürthle Cell Neoplasms in Papanicolaou- and Romanowsky-Stained Specimens. In: Kakudo, K. (eds) Thyroid FNA Cytology. Springer, Singapore. https://doi.org/10.1007/978-981-13-1897-9_47
Download citation
DOI: https://doi.org/10.1007/978-981-13-1897-9_47
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-1896-2
Online ISBN: 978-981-13-1897-9
eBook Packages: MedicineMedicine (R0)